Delphi project in bronchial asthma. Two stages.
From the paediatric point of view, we have undertaken two Delphi studies into bronchial asthma. The first is related to the consensus known as the consensus document of the five associations. The second is more recent and has been undertaken with GEMA (the Spanish Guidelines on the Management of Asthma). The aim of this paper is to carry out a descriptive study comparing the 2 Delphi processes and to objectively assess if in some way behaviour over the past two years has changed as far as expert opinion is concerned. In the consensus document those points giving rise to most controversy were the treatment of children under three years of age and treatment with immunotherapy in allergic asthma. It is also necessary to highlight how important it was at that particular point in time to define the phenotypes of wheezing and the predictive index of asthma in children of less than 3 years of age. Of the 52 questions in the questionnaire, in 13.6% the panel of experts reached no consensus in their positions. Following GEMA the Delphi methodology, 56 questions were asked in the first round of the questionnaire, and consensus was reached in 87.5%. As regards the paediatric part relating to diagnosis and treatment in children, agreement was reached on all the questions in the first round. Agreement was reached in 8.92% questions in the second round. Clinical guidelines and consensus documents can modify behaviour towards an illness, both in the diagnosis and treatment.
Fernández-Benítez
M
M
Clínica Universidad de Navarra, Pamplona, Spain. mfernandeb@unav.es
Ibero Iborra
M
M
Sanz Ortega
J
J
Garde Garde
J
J
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D002675:Child, Preschool; D032921:Consensus; D003245:Consensus Statements as Topic; D003697:Delphi Technique; D006801:Humans; D007167:Immunotherapy; D033183:Interdisciplinary Communication; D018579:Patient Selection; D017410:Practice Guidelines as Topic
D018927:Anti-Asthmatic Agents